Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
50 participants
OBSERVATIONAL
2021-11-01
2026-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Analysis of PHACE Syndrome (Hemangioma With Other Congenital Anomalies)
NCT01016756
Genetic Analysis of Patients With Pseudoxanthoma Elasticum
NCT00341419
Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
NCT00004351
Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults
NCT04702243
Genetic Study of Patients With Primary Ciliary Dyskinesia
NCT00005650
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnostic study only
Diagnostic study only
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be willing to have an eye examination
* Must be willing to undergo genetic testing
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karen Joos
Primary Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen Joos, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt Eye Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt Eye Institute
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
211300
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.